Nanobiotix S.A. NBTX
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -19.94M | -20.06M | -10.81M | -10.86M | -3.05M |
| Total Depreciation and Amortization | 455.90K | 458.60K | 403.40K | 405.10K | 454.00K |
| Total Amortization of Deferred Charges | 1.70K | 1.80K | 1.20K | 1.20K | -- |
| Total Other Non-Cash Items | 11.46M | 11.53M | 4.04M | 4.06M | -8.22M |
| Change in Net Operating Assets | -2.55M | -2.56M | -2.95M | -2.96M | 944.80K |
| Cash from Operations | -10.57M | -10.63M | -9.32M | -9.36M | -9.88M |
| Capital Expenditure | -364.60K | -366.80K | -225.80K | -226.80K | -85.10K |
| Sale of Property, Plant, and Equipment | 30.80K | 31.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 600.00 | 600.00 | -16.30K | -16.40K | -6.80K |
| Cash from Investing | -333.20K | -335.20K | -242.10K | -243.20K | -91.90K |
| Total Debt Issued | -- | -- | 21.47M | 21.47M | -- |
| Total Debt Repaid | -1.07M | -1.07M | -1.13M | -1.13M | -1.25M |
| Issuance of Common Stock | 38.48M | 38.48M | 767.50K | 767.50K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 842.00K | 842.00K | -986.00K | -986.00K | -168.00K |
| Cash from Financing | 44.48M | 44.75M | 23.43M | 23.53M | -1.61M |
| Foreign Exchange rate Adjustments | 230.30K | 231.70K | 65.80K | 66.10K | -292.20K |
| Miscellaneous Cash Flow Adjustments | -600.00 | -600.00 | 600.00 | 600.00 | -600.00 |
| Net Change in Cash | 33.81M | 34.01M | 13.93M | 13.99M | -11.87M |